nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefotetan—ALB—Captopril—systemic scleroderma	0.28	0.366	CbGbCtD
Cefotetan—ALB—Mycophenolate mofetil—systemic scleroderma	0.221	0.288	CbGbCtD
Cefotetan—ALB—Prednisone—systemic scleroderma	0.177	0.23	CbGbCtD
Cefotetan—ALB—Methotrexate—systemic scleroderma	0.0886	0.116	CbGbCtD
Cefotetan—Prothrombin level increased—Mycophenolic acid—systemic scleroderma	0.00547	0.0234	CcSEcCtD
Cefotetan—Cholestasis—Pentoxifylline—systemic scleroderma	0.00496	0.0212	CcSEcCtD
Cefotetan—Vaginal moniliasis—Leflunomide—systemic scleroderma	0.00466	0.02	CcSEcCtD
Cefotetan—Vulvovaginal candidiasis—Leflunomide—systemic scleroderma	0.00448	0.0191	CcSEcCtD
Cefotetan—Prothrombin level increased—Mycophenolate mofetil—systemic scleroderma	0.00432	0.0185	CcSEcCtD
Cefotetan—Vulvovaginal mycotic infection—Leflunomide—systemic scleroderma	0.0043	0.0184	CcSEcCtD
Cefotetan—Cholestasis—Captopril—systemic scleroderma	0.00376	0.0161	CcSEcCtD
Cefotetan—Aplastic anaemia—Pentoxifylline—systemic scleroderma	0.00354	0.0151	CcSEcCtD
Cefotetan—Vaginal moniliasis—Mycophenolate mofetil—systemic scleroderma	0.00351	0.015	CcSEcCtD
Cefotetan—Vulvovaginal candidiasis—Mycophenolate mofetil—systemic scleroderma	0.00337	0.0144	CcSEcCtD
Cefotetan—Cholestasis—Azathioprine—systemic scleroderma	0.00328	0.014	CcSEcCtD
Cefotetan—Vulvovaginal mycotic infection—Mycophenolate mofetil—systemic scleroderma	0.00324	0.0139	CcSEcCtD
Cefotetan—Cholestasis—Leflunomide—systemic scleroderma	0.0031	0.0133	CcSEcCtD
Cefotetan—Thrombocytosis—Mycophenolate mofetil—systemic scleroderma	0.00285	0.0122	CcSEcCtD
Cefotetan—Colitis—Azathioprine—systemic scleroderma	0.00239	0.0102	CcSEcCtD
Cefotetan—Aplastic anaemia—Azathioprine—systemic scleroderma	0.00234	0.01	CcSEcCtD
Cefotetan—Haemolytic anaemia—Captopril—systemic scleroderma	0.0023	0.00982	CcSEcCtD
Cefotetan—Colitis—Leflunomide—systemic scleroderma	0.00226	0.00967	CcSEcCtD
Cefotetan—Pancytopenia—Pentoxifylline—systemic scleroderma	0.00224	0.0096	CcSEcCtD
Cefotetan—Colitis—Mycophenolic acid—systemic scleroderma	0.00216	0.00922	CcSEcCtD
Cefotetan—Hepatic function abnormal—Azathioprine—systemic scleroderma	0.00207	0.00886	CcSEcCtD
Cefotetan—Haemoglobin—Pentoxifylline—systemic scleroderma	0.0019	0.00814	CcSEcCtD
Cefotetan—Haemorrhage—Pentoxifylline—systemic scleroderma	0.00189	0.00809	CcSEcCtD
Cefotetan—Phlebitis—Mycophenolic acid—systemic scleroderma	0.00189	0.00809	CcSEcCtD
Cefotetan—Eosinophilia—Captopril—systemic scleroderma	0.00177	0.00759	CcSEcCtD
Cefotetan—Pancytopenia—Captopril—systemic scleroderma	0.0017	0.00728	CcSEcCtD
Cefotetan—Colitis—Mycophenolate mofetil—systemic scleroderma	0.0017	0.00728	CcSEcCtD
Cefotetan—Hepatic function abnormal—Lisinopril—systemic scleroderma	0.00168	0.00719	CcSEcCtD
Cefotetan—Neutropenia—Captopril—systemic scleroderma	0.00167	0.00717	CcSEcCtD
Cefotetan—Aplastic anaemia—Mycophenolate mofetil—systemic scleroderma	0.00166	0.00712	CcSEcCtD
Cefotetan—Toxic epidermal necrolysis—Azathioprine—systemic scleroderma	0.00163	0.00697	CcSEcCtD
Cefotetan—Haemolytic anaemia—Lisinopril—systemic scleroderma	0.00163	0.00696	CcSEcCtD
Cefotetan—Stevens-Johnson syndrome—Captopril—systemic scleroderma	0.00158	0.00677	CcSEcCtD
Cefotetan—Toxic epidermal necrolysis—Leflunomide—systemic scleroderma	0.00154	0.00658	CcSEcCtD
Cefotetan—Phlebitis—Mycophenolate mofetil—systemic scleroderma	0.00149	0.00639	CcSEcCtD
Cefotetan—Agranulocytosis—Captopril—systemic scleroderma	0.00149	0.00638	CcSEcCtD
Cefotetan—Pancytopenia—Azathioprine—systemic scleroderma	0.00148	0.00635	CcSEcCtD
Cefotetan—Leukopenia—Pentoxifylline—systemic scleroderma	0.00147	0.00631	CcSEcCtD
Cefotetan—Eosinophilia—Leflunomide—systemic scleroderma	0.00146	0.00625	CcSEcCtD
Cefotetan—Convulsion—Pentoxifylline—systemic scleroderma	0.00143	0.00611	CcSEcCtD
Cefotetan—Haemolytic anaemia—Mycophenolate mofetil—systemic scleroderma	0.00142	0.00609	CcSEcCtD
Cefotetan—Pancytopenia—Leflunomide—systemic scleroderma	0.0014	0.006	CcSEcCtD
Cefotetan—Discomfort—Pentoxifylline—systemic scleroderma	0.00139	0.00593	CcSEcCtD
Cefotetan—Stevens-Johnson syndrome—Azathioprine—systemic scleroderma	0.00138	0.00591	CcSEcCtD
Cefotetan—Neutropenia—Leflunomide—systemic scleroderma	0.00138	0.00591	CcSEcCtD
Cefotetan—Erythema multiforme—Captopril—systemic scleroderma	0.00136	0.0058	CcSEcCtD
Cefotetan—Anaphylactic shock—Pentoxifylline—systemic scleroderma	0.00134	0.00575	CcSEcCtD
Cefotetan—Pancytopenia—Mycophenolic acid—systemic scleroderma	0.00134	0.00572	CcSEcCtD
Cefotetan—Toxic epidermal necrolysis—Lisinopril—systemic scleroderma	0.00132	0.00565	CcSEcCtD
Cefotetan—Neutropenia—Mycophenolic acid—systemic scleroderma	0.00132	0.00563	CcSEcCtD
Cefotetan—Thrombocytopenia—Pentoxifylline—systemic scleroderma	0.00132	0.00563	CcSEcCtD
Cefotetan—Stevens-Johnson syndrome—Leflunomide—systemic scleroderma	0.00131	0.00558	CcSEcCtD
Cefotetan—Agranulocytosis—Azathioprine—systemic scleroderma	0.0013	0.00557	CcSEcCtD
Cefotetan—Haemoglobin—Azathioprine—systemic scleroderma	0.00126	0.00538	CcSEcCtD
Cefotetan—Eosinophilia—Lisinopril—systemic scleroderma	0.00126	0.00537	CcSEcCtD
Cefotetan—Haemorrhage—Azathioprine—systemic scleroderma	0.00125	0.00535	CcSEcCtD
Cefotetan—Agranulocytosis—Leflunomide—systemic scleroderma	0.00123	0.00526	CcSEcCtD
Cefotetan—Pancytopenia—Lisinopril—systemic scleroderma	0.0012	0.00515	CcSEcCtD
Cefotetan—Haemoglobin—Leflunomide—systemic scleroderma	0.00119	0.00508	CcSEcCtD
Cefotetan—Neutropenia—Lisinopril—systemic scleroderma	0.00119	0.00508	CcSEcCtD
Cefotetan—Erythema multiforme—Azathioprine—systemic scleroderma	0.00118	0.00506	CcSEcCtD
Cefotetan—Haemorrhage—Leflunomide—systemic scleroderma	0.00118	0.00506	CcSEcCtD
Cefotetan—Agranulocytosis—Mycophenolic acid—systemic scleroderma	0.00117	0.00501	CcSEcCtD
Cefotetan—Anaphylactic shock—Mometasone—systemic scleroderma	0.00116	0.00496	CcSEcCtD
Cefotetan—Haemoglobin—Mycophenolic acid—systemic scleroderma	0.00113	0.00485	CcSEcCtD
Cefotetan—Haemorrhage—Mycophenolic acid—systemic scleroderma	0.00113	0.00482	CcSEcCtD
Cefotetan—Stevens-Johnson syndrome—Lisinopril—systemic scleroderma	0.00112	0.0048	CcSEcCtD
Cefotetan—Erythema multiforme—Leflunomide—systemic scleroderma	0.00112	0.00478	CcSEcCtD
Cefotetan—Gastrointestinal pain—Pentoxifylline—systemic scleroderma	0.0011	0.0047	CcSEcCtD
Cefotetan—Urticaria—Pentoxifylline—systemic scleroderma	0.00107	0.00457	CcSEcCtD
Cefotetan—Abdominal pain—Pentoxifylline—systemic scleroderma	0.00106	0.00455	CcSEcCtD
Cefotetan—Body temperature increased—Pentoxifylline—systemic scleroderma	0.00106	0.00455	CcSEcCtD
Cefotetan—Pancytopenia—Mycophenolate mofetil—systemic scleroderma	0.00106	0.00452	CcSEcCtD
Cefotetan—Agranulocytosis—Lisinopril—systemic scleroderma	0.00106	0.00452	CcSEcCtD
Cefotetan—Discomfort—Captopril—systemic scleroderma	0.00105	0.00449	CcSEcCtD
Cefotetan—Neutropenia—Mycophenolate mofetil—systemic scleroderma	0.00104	0.00445	CcSEcCtD
Cefotetan—Anaphylactic shock—Captopril—systemic scleroderma	0.00102	0.00436	CcSEcCtD
Cefotetan—Vaginal inflammation—Methotrexate—systemic scleroderma	0.001	0.00429	CcSEcCtD
Cefotetan—Thrombocytopenia—Captopril—systemic scleroderma	0.000997	0.00427	CcSEcCtD
Cefotetan—Hypersensitivity—Pentoxifylline—systemic scleroderma	0.00099	0.00424	CcSEcCtD
Cefotetan—Leukopenia—Azathioprine—systemic scleroderma	0.000975	0.00417	CcSEcCtD
Cefotetan—Erythema multiforme—Lisinopril—systemic scleroderma	0.00096	0.00411	CcSEcCtD
Cefotetan—Pruritus—Pentoxifylline—systemic scleroderma	0.000951	0.00407	CcSEcCtD
Cefotetan—Gastrointestinal pain—Mometasone—systemic scleroderma	0.000948	0.00406	CcSEcCtD
Cefotetan—Vaginal infection—Methotrexate—systemic scleroderma	0.000947	0.00405	CcSEcCtD
Cefotetan—Aplastic anaemia—Methotrexate—systemic scleroderma	0.000942	0.00403	CcSEcCtD
Cefotetan—Agranulocytosis—Mycophenolate mofetil—systemic scleroderma	0.000925	0.00396	CcSEcCtD
Cefotetan—Leukopenia—Leflunomide—systemic scleroderma	0.000921	0.00394	CcSEcCtD
Cefotetan—Diarrhoea—Pentoxifylline—systemic scleroderma	0.00092	0.00393	CcSEcCtD
Cefotetan—Abdominal pain—Mometasone—systemic scleroderma	0.000917	0.00392	CcSEcCtD
Cefotetan—Body temperature increased—Mometasone—systemic scleroderma	0.000917	0.00392	CcSEcCtD
Cefotetan—Discomfort—Azathioprine—systemic scleroderma	0.000916	0.00392	CcSEcCtD
Cefotetan—Haemoglobin—Mycophenolate mofetil—systemic scleroderma	0.000894	0.00383	CcSEcCtD
Cefotetan—Haemorrhage—Mycophenolate mofetil—systemic scleroderma	0.00089	0.00381	CcSEcCtD
Cefotetan—Leukopenia—Mycophenolic acid—systemic scleroderma	0.000878	0.00376	CcSEcCtD
Cefotetan—Thrombocytopenia—Azathioprine—systemic scleroderma	0.00087	0.00372	CcSEcCtD
Cefotetan—Discomfort—Leflunomide—systemic scleroderma	0.000865	0.0037	CcSEcCtD
Cefotetan—Vomiting—Pentoxifylline—systemic scleroderma	0.000855	0.00366	CcSEcCtD
Cefotetan—Convulsion—Mycophenolic acid—systemic scleroderma	0.00085	0.00364	CcSEcCtD
Cefotetan—Rash—Pentoxifylline—systemic scleroderma	0.000847	0.00363	CcSEcCtD
Cefotetan—Dermatitis—Pentoxifylline—systemic scleroderma	0.000847	0.00362	CcSEcCtD
Cefotetan—Anaphylactic shock—Leflunomide—systemic scleroderma	0.00084	0.00359	CcSEcCtD
Cefotetan—Gastrointestinal pain—Captopril—systemic scleroderma	0.000833	0.00356	CcSEcCtD
Cefotetan—Discomfort—Mycophenolic acid—systemic scleroderma	0.000825	0.00353	CcSEcCtD
Cefotetan—Thrombocytopenia—Leflunomide—systemic scleroderma	0.000822	0.00352	CcSEcCtD
Cefotetan—Pruritus—Mometasone—systemic scleroderma	0.000821	0.00351	CcSEcCtD
Cefotetan—Body temperature increased—Captopril—systemic scleroderma	0.000805	0.00345	CcSEcCtD
Cefotetan—Abdominal pain—Captopril—systemic scleroderma	0.000805	0.00345	CcSEcCtD
Cefotetan—Nausea—Pentoxifylline—systemic scleroderma	0.000798	0.00342	CcSEcCtD
Cefotetan—Diarrhoea—Mometasone—systemic scleroderma	0.000794	0.0034	CcSEcCtD
Cefotetan—Leukopenia—Lisinopril—systemic scleroderma	0.000791	0.00339	CcSEcCtD
Cefotetan—Thrombocytopenia—Mycophenolic acid—systemic scleroderma	0.000784	0.00336	CcSEcCtD
Cefotetan—Discomfort—Lisinopril—systemic scleroderma	0.000743	0.00318	CcSEcCtD
Cefotetan—Vomiting—Mometasone—systemic scleroderma	0.000737	0.00316	CcSEcCtD
Cefotetan—Rash—Mometasone—systemic scleroderma	0.000731	0.00313	CcSEcCtD
Cefotetan—Dermatitis—Mometasone—systemic scleroderma	0.000731	0.00313	CcSEcCtD
Cefotetan—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000727	0.00311	CcSEcCtD
Cefotetan—Anaphylactic shock—Lisinopril—systemic scleroderma	0.000721	0.00309	CcSEcCtD
Cefotetan—Pruritus—Captopril—systemic scleroderma	0.000721	0.00308	CcSEcCtD
Cefotetan—Thrombocytopenia—Lisinopril—systemic scleroderma	0.000706	0.00302	CcSEcCtD
Cefotetan—Neutropenia—Prednisone—systemic scleroderma	0.000704	0.00301	CcSEcCtD
Cefotetan—Body temperature increased—Azathioprine—systemic scleroderma	0.000703	0.00301	CcSEcCtD
Cefotetan—Abdominal pain—Azathioprine—systemic scleroderma	0.000703	0.00301	CcSEcCtD
Cefotetan—Diarrhoea—Captopril—systemic scleroderma	0.000697	0.00298	CcSEcCtD
Cefotetan—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.000693	0.00297	CcSEcCtD
Cefotetan—Nausea—Mometasone—systemic scleroderma	0.000689	0.00295	CcSEcCtD
Cefotetan—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000686	0.00294	CcSEcCtD
Cefotetan—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000671	0.00287	CcSEcCtD
Cefotetan—Urticaria—Leflunomide—systemic scleroderma	0.000667	0.00285	CcSEcCtD
Cefotetan—Abdominal pain—Leflunomide—systemic scleroderma	0.000664	0.00284	CcSEcCtD
Cefotetan—Body temperature increased—Leflunomide—systemic scleroderma	0.000664	0.00284	CcSEcCtD
Cefotetan—Toxic epidermal necrolysis—Methotrexate—systemic scleroderma	0.000656	0.00281	CcSEcCtD
Cefotetan—Hypersensitivity—Azathioprine—systemic scleroderma	0.000655	0.0028	CcSEcCtD
Cefotetan—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000655	0.0028	CcSEcCtD
Cefotetan—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000651	0.00279	CcSEcCtD
Cefotetan—Vomiting—Captopril—systemic scleroderma	0.000648	0.00277	CcSEcCtD
Cefotetan—Rash—Captopril—systemic scleroderma	0.000642	0.00275	CcSEcCtD
Cefotetan—Dermatitis—Captopril—systemic scleroderma	0.000642	0.00275	CcSEcCtD
Cefotetan—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000633	0.00271	CcSEcCtD
Cefotetan—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000633	0.00271	CcSEcCtD
Cefotetan—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000632	0.0027	CcSEcCtD
Cefotetan—Eosinophilia—Methotrexate—systemic scleroderma	0.000623	0.00267	CcSEcCtD
Cefotetan—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000619	0.00265	CcSEcCtD
Cefotetan—Hypersensitivity—Leflunomide—systemic scleroderma	0.000619	0.00265	CcSEcCtD
Cefotetan—Diarrhoea—Azathioprine—systemic scleroderma	0.000608	0.0026	CcSEcCtD
Cefotetan—Haemoglobin—Prednisone—systemic scleroderma	0.000606	0.00259	CcSEcCtD
Cefotetan—Nausea—Captopril—systemic scleroderma	0.000605	0.00259	CcSEcCtD
Cefotetan—Haemorrhage—Prednisone—systemic scleroderma	0.000603	0.00258	CcSEcCtD
Cefotetan—Pancytopenia—Methotrexate—systemic scleroderma	0.000598	0.00256	CcSEcCtD
Cefotetan—Pruritus—Leflunomide—systemic scleroderma	0.000594	0.00254	CcSEcCtD
Cefotetan—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.00059	0.00252	CcSEcCtD
Cefotetan—Neutropenia—Methotrexate—systemic scleroderma	0.000589	0.00252	CcSEcCtD
Cefotetan—Diarrhoea—Leflunomide—systemic scleroderma	0.000574	0.00246	CcSEcCtD
Cefotetan—Urticaria—Lisinopril—systemic scleroderma	0.000573	0.00245	CcSEcCtD
Cefotetan—Abdominal pain—Lisinopril—systemic scleroderma	0.00057	0.00244	CcSEcCtD
Cefotetan—Body temperature increased—Lisinopril—systemic scleroderma	0.00057	0.00244	CcSEcCtD
Cefotetan—Pruritus—Mycophenolic acid—systemic scleroderma	0.000567	0.00242	CcSEcCtD
Cefotetan—Vomiting—Azathioprine—systemic scleroderma	0.000565	0.00242	CcSEcCtD
Cefotetan—Rash—Azathioprine—systemic scleroderma	0.000561	0.0024	CcSEcCtD
Cefotetan—Dermatitis—Azathioprine—systemic scleroderma	0.00056	0.0024	CcSEcCtD
Cefotetan—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	0.000557	0.00238	CcSEcCtD
Cefotetan—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000548	0.00234	CcSEcCtD
Cefotetan—Vomiting—Leflunomide—systemic scleroderma	0.000534	0.00228	CcSEcCtD
Cefotetan—Hypersensitivity—Lisinopril—systemic scleroderma	0.000531	0.00227	CcSEcCtD
Cefotetan—Rash—Leflunomide—systemic scleroderma	0.000529	0.00226	CcSEcCtD
Cefotetan—Dermatitis—Leflunomide—systemic scleroderma	0.000529	0.00226	CcSEcCtD
Cefotetan—Nausea—Azathioprine—systemic scleroderma	0.000528	0.00226	CcSEcCtD
Cefotetan—Agranulocytosis—Methotrexate—systemic scleroderma	0.000524	0.00224	CcSEcCtD
Cefotetan—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000517	0.00221	CcSEcCtD
Cefotetan—Pruritus—Lisinopril—systemic scleroderma	0.00051	0.00218	CcSEcCtD
Cefotetan—Vomiting—Mycophenolic acid—systemic scleroderma	0.000509	0.00218	CcSEcCtD
Cefotetan—Haemoglobin—Methotrexate—systemic scleroderma	0.000507	0.00217	CcSEcCtD
Cefotetan—Rash—Mycophenolic acid—systemic scleroderma	0.000505	0.00216	CcSEcCtD
Cefotetan—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000505	0.00216	CcSEcCtD
Cefotetan—Haemorrhage—Methotrexate—systemic scleroderma	0.000504	0.00216	CcSEcCtD
Cefotetan—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000502	0.00215	CcSEcCtD
Cefotetan—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.0005	0.00214	CcSEcCtD
Cefotetan—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.0005	0.00214	CcSEcCtD
Cefotetan—Nausea—Leflunomide—systemic scleroderma	0.000499	0.00213	CcSEcCtD
Cefotetan—Diarrhoea—Lisinopril—systemic scleroderma	0.000494	0.00211	CcSEcCtD
Cefotetan—Erythema multiforme—Methotrexate—systemic scleroderma	0.000477	0.00204	CcSEcCtD
Cefotetan—Nausea—Mycophenolic acid—systemic scleroderma	0.000476	0.00204	CcSEcCtD
Cefotetan—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000466	0.00199	CcSEcCtD
Cefotetan—Vomiting—Lisinopril—systemic scleroderma	0.000459	0.00196	CcSEcCtD
Cefotetan—Rash—Lisinopril—systemic scleroderma	0.000455	0.00195	CcSEcCtD
Cefotetan—Convulsion—Prednisone—systemic scleroderma	0.000455	0.00195	CcSEcCtD
Cefotetan—Dermatitis—Lisinopril—systemic scleroderma	0.000454	0.00194	CcSEcCtD
Cefotetan—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000447	0.00191	CcSEcCtD
Cefotetan—Discomfort—Prednisone—systemic scleroderma	0.000442	0.00189	CcSEcCtD
Cefotetan—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000432	0.00185	CcSEcCtD
Cefotetan—Nausea—Lisinopril—systemic scleroderma	0.000428	0.00183	CcSEcCtD
Cefotetan—Anaphylactic shock—Prednisone—systemic scleroderma	0.000428	0.00183	CcSEcCtD
Cefotetan—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000402	0.00172	CcSEcCtD
Cefotetan—Rash—Mycophenolate mofetil—systemic scleroderma	0.000399	0.00171	CcSEcCtD
Cefotetan—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000398	0.0017	CcSEcCtD
Cefotetan—Leukopenia—Methotrexate—systemic scleroderma	0.000393	0.00168	CcSEcCtD
Cefotetan—Convulsion—Methotrexate—systemic scleroderma	0.00038	0.00163	CcSEcCtD
Cefotetan—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000375	0.00161	CcSEcCtD
Cefotetan—Discomfort—Methotrexate—systemic scleroderma	0.000369	0.00158	CcSEcCtD
Cefotetan—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000358	0.00153	CcSEcCtD
Cefotetan—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000351	0.0015	CcSEcCtD
Cefotetan—Gastrointestinal pain—Prednisone—systemic scleroderma	0.00035	0.0015	CcSEcCtD
Cefotetan—Urticaria—Prednisone—systemic scleroderma	0.00034	0.00146	CcSEcCtD
Cefotetan—Body temperature increased—Prednisone—systemic scleroderma	0.000339	0.00145	CcSEcCtD
Cefotetan—Abdominal pain—Prednisone—systemic scleroderma	0.000339	0.00145	CcSEcCtD
Cefotetan—Hypersensitivity—Prednisone—systemic scleroderma	0.000316	0.00135	CcSEcCtD
Cefotetan—Pruritus—Prednisone—systemic scleroderma	0.000303	0.0013	CcSEcCtD
Cefotetan—Diarrhoea—Prednisone—systemic scleroderma	0.000293	0.00125	CcSEcCtD
Cefotetan—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000293	0.00125	CcSEcCtD
Cefotetan—Urticaria—Methotrexate—systemic scleroderma	0.000284	0.00122	CcSEcCtD
Cefotetan—Abdominal pain—Methotrexate—systemic scleroderma	0.000283	0.00121	CcSEcCtD
Cefotetan—Body temperature increased—Methotrexate—systemic scleroderma	0.000283	0.00121	CcSEcCtD
Cefotetan—Vomiting—Prednisone—systemic scleroderma	0.000272	0.00117	CcSEcCtD
Cefotetan—Rash—Prednisone—systemic scleroderma	0.00027	0.00116	CcSEcCtD
Cefotetan—Dermatitis—Prednisone—systemic scleroderma	0.00027	0.00115	CcSEcCtD
Cefotetan—Hypersensitivity—Methotrexate—systemic scleroderma	0.000264	0.00113	CcSEcCtD
Cefotetan—Nausea—Prednisone—systemic scleroderma	0.000254	0.00109	CcSEcCtD
Cefotetan—Pruritus—Methotrexate—systemic scleroderma	0.000253	0.00108	CcSEcCtD
Cefotetan—Diarrhoea—Methotrexate—systemic scleroderma	0.000245	0.00105	CcSEcCtD
Cefotetan—Vomiting—Methotrexate—systemic scleroderma	0.000228	0.000974	CcSEcCtD
Cefotetan—Rash—Methotrexate—systemic scleroderma	0.000226	0.000966	CcSEcCtD
Cefotetan—Dermatitis—Methotrexate—systemic scleroderma	0.000226	0.000965	CcSEcCtD
Cefotetan—Nausea—Methotrexate—systemic scleroderma	0.000213	0.00091	CcSEcCtD
